FULC

Fulcrum Therapeutics, Inc.$3.88+0.04 (+0.91%)

Prev Close$3.85·MCap$294.5M·P/E—·Vol1.12M·Yield—

▲

Buys (12M)

$1.49M

▼

Sells (12M)

$938.6K

◆

Net Activity

Net Buyer

$547.1K

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Fulcrum Therapeutics, Inc. (FULC) has been mixed between buying and selling, with 2 insider purchases totaling $1.49M and 6 insider sales totaling $938.6K. The most recent insider transaction was by TANG KEVIN (10 percent owner), who purchased $594.7K worth of shares on Jul 20, 2026. Fulcrum Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $294.5M.

FULC Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jul 20, 2026	TANG KEVIN	10 percent owner	Buy	167,616	$3.55	$594.7K	7,080,945
Jul 15, 2026	TANG KEVIN	10 percent owner	Buy	249,946	$3.57	$891.1K	6,913,329
Jun 30, 2026	Ezekowitz Alan	director	Sell	18,000	$3.65	$65.6K	10,927-62%
Feb 4, 2026	Gould Robert J	director	Sell	30,000	$10.80	$323.9K	469,864
Feb 2, 2026	Gould Robert J	Director	Sell	15,000	$10.72	$160.9K	0
Jan 2, 2026	Gould Robert J	Director	Sell	15,000	$11.87	$178.1K	0
Dec 15, 2025	Oltmans Curtis Gale	Chief Legal Officer	Sell	3,452	$12.92	$44.6K	0
Nov 19, 2025	Gould Robert J	Director	Sell	15,000	$11.03	$165.5K	0
May 8, 2025	Tourangeau Greg	Principal Accounting Officer	Sell	498	$5.06	$2.5K	0
May 9, 2024	Tourangeau Greg	Principal Accounting Officer	Sell	236	$7.76	$1.8K	11,571
Mar 8, 2024	Tourangeau Greg	Vice President, Finance	Sell	4,884	$11.72	$57.2K	11,807-29%
Mar 5, 2024	Sapir Alex	See Remarks	Buy	43,360	$11.35	$492.0K	43,360
May 11, 2023	Tourangeau Greg	Principal Accounting Officer	Sell	210	$3.31	$695.10	15,992
Jan 24, 2023	RA CAPITAL MANAGEMENT, L.P.	10% Owner	Buy	1,923,076	$13.00	$25.00M3.6% OS	11,609,704
Jan 13, 2023	Gould Robert J	Interim President & CEO	Sell	6,766	$15.00	$101.5K	499,864
Jan 6, 2023	RA CAPITAL MANAGEMENT, L.P.	10% Owner	Buy	180,703	$7.28	$1.31M	9,686,628
Dec 29, 2022	RA CAPITAL MANAGEMENT, L.P.	10% Owner	Buy	4,089	$5.99	$24.5K	9,505,925
Dec 21, 2022	RA CAPITAL MANAGEMENT, L.P.	10% Owner	Buy	98,787	$5.90	$582.8K	9,501,836
Dec 16, 2022	RA CAPITAL MANAGEMENT, L.P.	10% Owner	Buy	2,403,049	$5.44	$13.07M4.4% OS	9,403,049+34%
Jun 8, 2022	Gould Robert J	Director	Sell	71,435	$8.09	$577.9K	506,630
Jun 6, 2022	Gould Robert J	Director	Sell	66,622	$8.00	$532.8K	506,630
Apr 11, 2022	Gould Robert J	Director	Sell	5,631	$24.01	$135.2K	506,630
Apr 5, 2022	Gould Robert J	Director	Sell	94,251	$24.16	$2.28M	506,630
Aug 12, 2021	Moxham Christopher	Chief Scientific Officer	Sell	51,785	$17.60	$911.4K	0Exit
Aug 12, 2021	Stuart Bryan	See Remarks	Sell	60,000	$20.42	$1.23M	0Exit
Jun 29, 2021	GERAGHTY JAMES A	Director	Buy	10,000	$9.16	$91.6K	90,714
Jun 29, 2021	Morabito Christopher	Chief Medical Officer	Buy	1,100	$9.16	$10.1K	1,100
Jun 29, 2021	Oltmans Curtis Gale	SVP, General Counsel	Buy	1,088	$9.01	$9.8K	1,088
Jun 29, 2021	Thomson Peter G.	VP Finance & Accounting	Buy	2,300	$9.00	$20.7K	2,300
Mar 17, 2021	Gould Robert J	See Remarks	Sell	10,000	$12.16	$121.6K	507,419

FULC Insider Buying Activity

The following table shows recent insider purchases of Fulcrum Therapeutics, Inc. (FULC) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jul 20, 2026	TANG KEVIN	10 percent owner	Buy	167,616	$3.55	$594.7K	7,080,945
Jul 15, 2026	TANG KEVIN	10 percent owner	Buy	249,946	$3.57	$891.1K	6,913,329
Mar 5, 2024	Sapir Alex	See Remarks	Buy	43,360	$11.35	$492.0K	43,360
Jan 24, 2023	RA CAPITAL MANAGEMENT, L.P.	10% Owner	Buy	1,923,076	$13.00	$25.00M3.6% OS	11,609,704
Jan 6, 2023	RA CAPITAL MANAGEMENT, L.P.	10% Owner	Buy	180,703	$7.28	$1.31M	9,686,628
Dec 29, 2022	RA CAPITAL MANAGEMENT, L.P.	10% Owner	Buy	4,089	$5.99	$24.5K	9,505,925
Dec 21, 2022	RA CAPITAL MANAGEMENT, L.P.	10% Owner	Buy	98,787	$5.90	$582.8K	9,501,836
Dec 16, 2022	RA CAPITAL MANAGEMENT, L.P.	10% Owner	Buy	2,403,049	$5.44	$13.07M4.4% OS	9,403,049+34%
Jun 29, 2021	GERAGHTY JAMES A	Director	Buy	10,000	$9.16	$91.6K	90,714
Jun 29, 2021	Morabito Christopher	Chief Medical Officer	Buy	1,100	$9.16	$10.1K	1,100
Jun 29, 2021	Oltmans Curtis Gale	SVP, General Counsel	Buy	1,088	$9.01	$9.8K	1,088
Jun 29, 2021	Thomson Peter G.	VP Finance & Accounting	Buy	2,300	$9.00	$20.7K	2,300

FULC Insider Selling Activity

The following table shows recent insider sales of Fulcrum Therapeutics, Inc. (FULC) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jun 30, 2026	Ezekowitz Alan	director	Sell	18,000	$3.65	$65.6K	10,927-62%
Feb 4, 2026	Gould Robert J	director	Sell	30,000	$10.80	$323.9K	469,864
Feb 2, 2026	Gould Robert J	Director	Sell	15,000	$10.72	$160.9K	0
Jan 2, 2026	Gould Robert J	Director	Sell	15,000	$11.87	$178.1K	0
Dec 15, 2025	Oltmans Curtis Gale	Chief Legal Officer	Sell	3,452	$12.92	$44.6K	0
Nov 19, 2025	Gould Robert J	Director	Sell	15,000	$11.03	$165.5K	0
May 8, 2025	Tourangeau Greg	Principal Accounting Officer	Sell	498	$5.06	$2.5K	0
May 9, 2024	Tourangeau Greg	Principal Accounting Officer	Sell	236	$7.76	$1.8K	11,571
Mar 8, 2024	Tourangeau Greg	Vice President, Finance	Sell	4,884	$11.72	$57.2K	11,807-29%
May 11, 2023	Tourangeau Greg	Principal Accounting Officer	Sell	210	$3.31	$695.10	15,992
Jan 13, 2023	Gould Robert J	Interim President & CEO	Sell	6,766	$15.00	$101.5K	499,864
Jun 8, 2022	Gould Robert J	Director	Sell	71,435	$8.09	$577.9K	506,630
Jun 6, 2022	Gould Robert J	Director	Sell	66,622	$8.00	$532.8K	506,630
Apr 11, 2022	Gould Robert J	Director	Sell	5,631	$24.01	$135.2K	506,630
Apr 5, 2022	Gould Robert J	Director	Sell	94,251	$24.16	$2.28M	506,630
Aug 12, 2021	Moxham Christopher	Chief Scientific Officer	Sell	51,785	$17.60	$911.4K	0Exit
Aug 12, 2021	Stuart Bryan	See Remarks	Sell	60,000	$20.42	$1.23M	0Exit
Mar 17, 2021	Gould Robert J	See Remarks	Sell	10,000	$12.16	$121.6K	507,419